TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill June 27, 1986